Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Dear SOLO Stock Fans, a Big Catalyst Is Rolling Out Today

Today marks the first day of customer deliveries for ElectraMeccanica's core SOLO EV, something that has had little impact on SOLO stock.

WBX Stock: 7 Things to Know as EV Charging Leader Wallbox Starts Trading Today

Here's what investors may want to know about WBX stock, as Wallbox officially starts trading today to great anticipation.

FAMI Stock: 7 Things to Know About the CEO Letter Sending Farmmi Higher

Following a rather bearish few months for investors in Chinese agriculture play Farmmi, FAMI stock is bringing some green to investors today .

WISH Stock: What Is Going on With Retail Favorite ContextLogic Today?

Here's what investors in ContextLogic are watching today, as WISH stock's share price drops by 8% amid heavy trading.

XENE Stock: The Huge FDA News Sending Xenon Pharmaceuticals to the Moon

Here's why investors in clinical-stage biotech stock Xenon Pharmaceuticals are cheering today as XENE stock runs wild.